Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”
Joint Authors
Ouyang, Yuli
Han, Jing
Guo, Shuzhen
Wang, Wei
Guo, Shuzhen
Liu, Zhongyang
Li, Dong
Yu, Junda
Wang, Yong
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-01-10
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2” [1], the wrong TCM remedy was cited in the Introduction.
The article focuses on the pharmacological effect of Qishenyiqi (QSYQ) on coronary heart disease, but two articles about Qishenyiqi drop pill, which has a similar name and the same abbreviation, QSYQ, were inappropriately discussed as references 2 and 3.
Both remedies include Radix Astragali mongolici (‘huang-qi’ in Chinese) and Salvia miltiorrhiza bunge (‘dan-shen’ in Chinese).
American Psychological Association (APA)
Wang, Yong& Guo, Shuzhen& Ouyang, Yuli& Yu, Junda& Guo, Shuzhen& Liu, Zhongyang…[et al.]. 2019. Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”. Evidence-Based Complementary and Alternative Medicine،Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1151932
Modern Language Association (MLA)
Wang, Yong…[et al.]. Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”. Evidence-Based Complementary and Alternative Medicine No. 2019 (2019), pp.1-1.
https://search.emarefa.net/detail/BIM-1151932
American Medical Association (AMA)
Wang, Yong& Guo, Shuzhen& Ouyang, Yuli& Yu, Junda& Guo, Shuzhen& Liu, Zhongyang…[et al.]. Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”. Evidence-Based Complementary and Alternative Medicine. 2019. Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1151932
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1151932
